Name: UMIN ID:
Unique ID issued by UMIN | UMIN000000708 |
---|---|
Receipt number | R000000844 |
Scientific Title | Efficacy and Safety of mizoribine for MPO-ANCA associated vasculitis; A multicenter randomized controlled trial (Mizoribin for ANCA RPGN Relapse-Prevention study:MARPGN study) |
Date of disclosure of the study information | 2007/05/06 |
Last modified on | 2013/05/07 08:13:07 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2007/05/06 16:19:57 | ||
2 | Update | 2008/12/15 18:22:55 | Name of person sending information |
|
3 | Update | 2008/12/15 18:23:53 | Last follow-up date |
|
4 | Update | 2008/12/15 18:30:17 | Organization Organization Division name Division name Organization Organization Division name Division name Organization Organization Division name Division name |
|
5 | Update | 2009/05/30 17:33:29 | Public title Acronym Acronym |
|
6 | Update | 2009/11/06 18:44:37 | Recruitment status Last follow-up date |
|
7 | Update | 2011/05/07 13:43:13 | Last follow-up date |
|
8 | Update | 2011/11/06 13:43:00 | Last follow-up date |
|
9 | Update | 2012/05/07 08:15:45 | Organization Organization Division name Division name Organization Organization Division name Division name Organization Organization Division name Division name Institute Institute Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
10 | Update | 2012/05/07 08:16:36 | Recruitment status |
|
11 | Update | 2012/11/06 16:11:25 | Last follow-up date |
|
12 | Update | 2013/05/07 08:13:07 | Recruitment status |